1. Home
  2. WETH vs AEON Comparison

WETH vs AEON Comparison

Compare WETH & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

WETH

Wetouch Technology Inc.

HOLD

Current Price

$1.39

Market Cap

21.1M

Sector

N/A

ML Signal

HOLD

Logo AEON Biopharma Inc.

AEON

AEON Biopharma Inc.

HOLD

Current Price

$1.03

Market Cap

25.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WETH
AEON
Founded
1992
N/A
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.1M
25.2M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
WETH
AEON
Price
$1.39
$1.03
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$7.20
AVG Volume (30 Days)
52.0K
79.3K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.61
N/A
Revenue
$42,280,373.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$2.34
N/A
Revenue Growth
6.48
N/A
52 Week Low
$0.76
$0.38
52 Week High
$3.68
$1.45

Technical Indicators

Market Signals
Indicator
WETH
AEON
Relative Strength Index (RSI) 33.47 45.18
Support Level $1.22 $1.02
Resistance Level $1.42 $1.10
Average True Range (ATR) 0.17 0.12
MACD -0.05 -0.01
Stochastic Oscillator 8.00 17.14

Price Performance

Historical Comparison
WETH
AEON

About WETH Wetouch Technology Inc.

Wetouch Technology Inc is a touch panel supplier focused on R&D, production, and sales of touch screen products. It offers touchscreens for a variety of applications, including GPS/car entertainment panels for the automotive industry, industrial human-machine interface, financial and banking terminals, point of sale, lottery and gaming machines, smart home, robots, and charging stations. The company sells touchscreen products both domestically in China and internationally. The company generates the majority of its revenue from the PRC, followed by the Republic of China and Korea.

About AEON AEON Biopharma Inc.

AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.

Share on Social Networks: